Table 2.
Detailed demographic and clinical characteristics of study participants
| Case No. | Age (y) | Sex | Laterality | Diagnosis | CMT (μm) | Lens status | Additional clinical information |
|---|---|---|---|---|---|---|---|
| 1 | 69 | M | OD | Diabetic macular edema. | 213 | Pseudophakic | Prior 32 intravitreal ranibizumab injections and 5 intravitreal dexamethasone implants. |
| 2 | 71 | M | OD | Lamellar macular hole. | 167 | Phakic | - |
| 3 | 48 | F | OS | After VRS for epiretinal membrane. | 367 | Phakic | Disorganization of inner retinal layers on OCT. |
| 4 | 63 | F | OD OS |
Vitreomacular traction. After VRS for FTMH. |
165 152 |
Phakic Phakic |
- |
| 5 | 61 | M | OD | After VRS for FTMH. | 244 | Pseudophakic | Mild subfoveal fluid on OCT. |
| 6 | 79 | F | OS | Microhole. | 214 | Phakic | - |
| 7 | 62 | F | OD | After VRS for FTMH. | 209 | Pseudophakic | Steepening of the foveal contour. |
| 8 | 61 | M | OD OS |
MacTel-2. MacTel-2. |
198 194 |
Phakic Phakic |
- |
| 9 | 34 | F | OD | NA-ION and central retinal artery occlusion. | 498 | Phakic | Second trimester of pregnancy. |
| 10 | 13 | M | OD | Microhole. | 193 | Phakic | - |
| 11 | 10 | F | OD | Microhole. | 196 | Phakic | - |
| 12 | 66 | F | OD | Exudative age-related macular degeneration. | 200 | Phakic | Prior 7 intravitreal aflibercept injections. |
| 13 | 65 | F | OS | After VRS for FTMH. | 196 | Phakic | - |
| 14 | 72 | M | OD | Lamellar macular hole. | 183 | Phakic | - |
| 15 | 62 | F | OS | After VRS for FTMH. | 180 | Pseudophakic | - |
| 16 | 70 | F | OS | Microhole. | 162 | Phakic | - |
| 17 | 61 | M | OS | Non-infectious idiopathic posterior uveitis. | 225 | Phakic | - |
| 18 | 59 | F | OD | MacTel-2. | 224 | Phakic | - |
| 19 | 77 | F | OD | Microhole. | 191 | Pseudophakic | - |
| 20 | 68 | F | OD | Lamellar macular hole. | 232 | Phakic | - |
| 21 | 74 | F | OS | Epiretinal membrane. | 270 | Phakic | - |
| 22 | 61 | M | OS | After VRS for FTMH. | 176 | Pseudophakic | Loss of the subfoveal ellipsoid zone on OCT. |
| 23 | 64 | F | OD | After VRS for FTMH. | 138 | Pseudophakic | Steepening of the foveal contour. |
| 24 | 67 | F | OD | Microhole. | 191 | Phakic | - |
| 25 | 53 | M | OS | After VRS for rhegmatogenous retinal detachment. | 132 | Phakic | Disorganization of the ellipsoid zone on OCT. |
| 26 | 10 | M | OS | Coats’ disease. | 172 | Phakic | Prior 2 intravitreal dexamethasone implants. |
| 27 | 51 | M | OD | Lamellar macular hole. | 239 | Phakic | - |
| 28 | 66 | M | OS | Before FTMH. | 155 | Phakic | - |
| 29 | 74 | F | OD | After VRS for FTMH. | 184 | Pseudophakic | - |
| 30 | 65 | M | OD | Before FTMH. | 161 | Phakic | - |
| 31 | 65 | M | OS | Diabetic macular edema. | 215 | Phakic | Prior 2 intravitreal ranibizumab injections. |
| 32 | 74 | M | OS | After VRS for FTMH. | 251 | Pseudophakic | - |
| 33 | 70 | M | OD | Before FTMH. | 187 | Pseudophakic | - |
| 34 | 64 | F | OD | After VRS for FTMH. | 160 | Pseudophakic | - |
| 35 | 61 | F | OD | After VRS for FTMH. | 170 | Pseudophakic | - |
| 36 | 40 | M | OS | Commotio retinae. | 192 | Phakic | - |
| 37 | 60 | M | OS | Diabetic macular edema. | 264 | Phakic | Prior 31 intravitreal aflibercept injection and 2 intravitreal dexamethasone implants. |
| 38 | 50 | M | OS | After VRS for FTMH, | 181 | Pseudophakic | - |
Abbreviations: y, years; CMT, central macular thickness; μm, micrometers; M, male; OD, right eye; F, female; OS, left eye; VRS, vitreoretinal surgery; OCT, optical coherence tomography; FTMH, full-thickness macular hole; MacTel-2, type-2 idiopathic macular telangiectasia; NA-ION, non-arteritic anterior ischemic optic neuropathy.